课题基金 / 基金详情

Control of Prostate-Specific Gene Expression

Control of Prostate-Specific Gene Expression
前列腺特异性基因表达的控制
批准号:
8434198
负责人:
ROBERT J. MATUSIK
金额:
$32.09万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1999
资助国家:
美国
项目状态:
已结题
起止时间:
1999-09-30 至 2015-03-31

项目摘要

项目成果

ROBERT J. MATUSIK的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Understanding the mechanism that controls prostate-specific gene expression has already resulted in the identification of FoxA1 as an important co-regulator of AR action as well as prostate development. We have now demonstrated that USF2 interacts with FoxA1 on multiple prostate-specific promoters. This indicates that USF2 functions to promote expression of genes associated with differentiation consistent with previously reported mechanism whereby USF2 inhibits proliferation by down regulating c-myc. Controlling prostate- specific gene expression with a complex of AR (signal dependent), FOXA1 (developmental cell specific for endoderm) and USF2 (differentiation specific) reveals a remarkable coming together of regulatory factors to dictate prostate-specific gene expression. Continuing work using tagged FOXA1 for affinity purification followed with Liquid Chromatography/Tandem Mass Spectrometry (LC-MS/MS) has identified 16 nuclear proteins that met the requirement of at least two peptide hits per protein in two separate experiments. Of these, 7 nuclear proteins can be either directly or indirectly linked to AR/FOXA1 action. Determining the factors that control prostate-specific gene expression has important implications for the understanding of cell fate during prostate development, androgen regulation of prostate disease, as well as understanding the fundamental cascade that controls cell determination and cell differentiation. Based upon published and our preliminary data, our Hypothesis is that by identifying the TFs that control prostate-specific gene expression, we are also identifying TF that play a critical role in prostate development. Three specific aims are proposed: Aim 1: To characterize the transcription factor complex of AR-regulated prostate-specific genes; Aim 2: To identify novel FOXA1 binding partners by tandem affinity purification followed with Liquid Chromatography/Tandem Mass Spectrometry (LC-MS/MS); Aim 3: To determine the function of identified TFs in prostate development and androgen dependence. Determining the remaining TFs that control prostate-specific gene expression has important implications for the understanding the factors that control androgen regulation of prostatic diseases such as hBPH and PCa.
期刊论文(13)
专著(0)
科研奖励(0)
会议论文
Upstream stimulatory factor 2, a novel FoxA1-interacting protein, is involved in prostate-specific gene expression.
上游刺激因子 2 是一种新型 FoxA1 相互作用蛋白,参与前列腺特异性基因表达。
DOI: 10.1210/me.2009-0092
发表时间: 2009
期刊: Molecular endocrinology (Baltimore, Md.)
影响因子: --
作者: [Sun,Qian, Yu,Xiuping, Degraff,DavidJ, Matusik,RobertJ]
通讯作者: Matusik,RobertJ
DOI: 10.1002/pros.22868
发表时间: 2014-11
期刊: PROSTATE
影响因子: 2.8
作者: [Valkenburg, Kenneth C., Yu, Xiuping, De Marzo, Angelo M., Spiering, Tyler J., Matusik, Robert J., Williams, Bart O.]
通讯作者: Williams, Bart O.
A small composite probasin promoter confers high levels of prostate-specific gene expression through regulation by androgens and glucocorticoids in vitro and in vivo.
小型复合 Probasin 启动子通过体外和体内雄激素和糖皮质激素的调节赋予高水平的前列腺特异性基因表达。
DOI: 10.1210/endo.141.12.7837
发表时间: 2000
期刊: Endocrinology.
影响因子: --
作者: [Zhang,J, Thomas,TZ, Kasper,S, Matusik,RJ]
通讯作者: Matusik,RJ
The NF-KappaB-Androgen Receptor Axis Drives Failure of Medical Therapy in Human Benign Prostatic Hyperplasia
Project 2: Fetuin-A in Prostate Cancer
Project 2: Fetuin-A in Prostate Cancer
Control of Prostate-Specific Gene Expression
  • 批准号:
    7859356
  • 项目类别:
  • 资助金额:
    $2.11万
  • 财政年份:
    2009
  • 负责人:
    ROBERT J. MATUSIK
  • 依托单位:
海外基金